Christopher A. Chapman
CIK 1520179 · SVP and CFO · last filed 2018-03-01
Christopher A. Chapman is a SVP and CFO who has filed 26 SEC Form 4 insider transactions across 1 company since 2012. The most recent filing shows the insider bought $48.1K of DBD on Mar 1, 2018. Across all open-market trades the lifetime net is −$210.9K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $4.4M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
DBD price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
NORTH CANTON, OH 44720
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| DBD | SVP and CFO | 72,138 | $60.31 | $4.35M | -$210.9K | 26 | 2018-03-01 |
Recent Filings
26 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2018-03-01 | DBD | Buy (P) | +3,000 | $48.1K | EDGAR |
| 2018-02-15 | DBD | Mixed | +2,474 | -$28.8K | EDGAR |
| 2018-02-12 | DBD | Tax (F) | −2,798 | -$44.3K | EDGAR |
| 2018-02-07 | DBD | Tax (F) | −2,086 | -$34.4K | EDGAR |
| 2018-02-06 | DBD | Tax (F) | −1,270 | -$22.2K | EDGAR |
| 2018-02-06 | DBD | Grant (A) | — | $0 | EDGAR |
| 2018-02-05 | DBD | Grant (A) | +23,007 | $431.4K | EDGAR |
| 2017-07-24 | DBD | Buy (P) | +2,000 | $43.1K | EDGAR |
| 2017-02-16 | DBD | Mixed | +1,086 | $31.8K | EDGAR |
| 2017-02-14 | DBD | Tax (F) | −1,598 | -$43.8K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.